Research ArticleDrug Discovery and Translational Medicine
Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet–Induced Obese Rats
Thomas B. Estridge, Asim B. Dey, Charles Reidy, Xiaohong Yu, Yuke Zhang, Maryalice Hartley, Paul L. Milligan, Najia Jin, Mark C. Kowala, Jennifer K. Leohr, Adrian J. Fretland, Thomas E. Mabry, Debra Luffer-Atlas and M. Jane Luo
Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 108-118; DOI: https://doi.org/10.1124/jpet.117.240242
Thomas B. Estridge
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Asim B. Dey
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Charles Reidy
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Xiaohong Yu
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Yuke Zhang
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Maryalice Hartley
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Paul L. Milligan
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Najia Jin
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Mark C. Kowala
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Jennifer K. Leohr
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Adrian J. Fretland
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Thomas E. Mabry
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
Debra Luffer-Atlas
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
M. Jane Luo
CardioMet Disease/Diabetic Complications (T.B.E., A.B.D., C.R., X.Y., Y.Z., N.J., M.H., M.C.K, M.J.L.), Discovery Chemistry and Research Technologies (P.L.M., T.E.M.), Global PK/PD & Pharmacometrics (J.K.L.), Drug Disposition (A.J.F., D.L.-A.), Eli Lilly & Co., Indianapolis, Indiana
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleDrug Discovery and Translational Medicine
4-APP Metabolite May Contribute to LY2584072 Hypolipidemic Effects
Thomas B. Estridge, Asim B. Dey, Charles Reidy, Xiaohong Yu, Yuke Zhang, Maryalice Hartley, Paul L. Milligan, Najia Jin, Mark C. Kowala, Jennifer K. Leohr, Adrian J. Fretland, Thomas E. Mabry, Debra Luffer-Atlas and M. Jane Luo
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 108-118; DOI: https://doi.org/10.1124/jpet.117.240242
Research ArticleDrug Discovery and Translational Medicine
4-APP Metabolite May Contribute to LY2584072 Hypolipidemic Effects
Thomas B. Estridge, Asim B. Dey, Charles Reidy, Xiaohong Yu, Yuke Zhang, Maryalice Hartley, Paul L. Milligan, Najia Jin, Mark C. Kowala, Jennifer K. Leohr, Adrian J. Fretland, Thomas E. Mabry, Debra Luffer-Atlas and M. Jane Luo
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 108-118; DOI: https://doi.org/10.1124/jpet.117.240242
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement